Leerink Initiates Coverage On Five Prime Therapeutics

By: via Benzinga
Leerink initiated coverage on Five Prime Therapeutics Inc (NASDAQ: FPRX) Thursday with an Outperform rating and $35 price ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.